Less Ads, More Data, More Tools Register for FREE

Pin to quick picksYGEN.L Regulatory News (YGEN)

  • There is currently no data for YGEN

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Senior Appointment

30 Jan 2008 07:01

ViaLogy PLC30 January 2008 VIALOGY PLC APPOINTS HEAD OF OPERATIONS AND ENGINEERING London, January 30, 2008 - ViaLogy PLC (AIM: VIY), a leading innovator ofnetwork-centric real time signal processing platforms for integrated security,safety, operations management and business continuity applications, todayannounces the appointment of Hugo Fruehauf as Chief Operating Officer (COO) andVice President of Engineering at its wholly-owned American subsidiary company,ViaLogy LLC ('ViaLogy'), of Pasadena, California. This senior appointment strengthens the company's engineering and productioncapabilities and advances efforts to establish its unique product offerings -Sensor Policy Manager (SPM), MicroSPM and MPEX Electronic Eye - in high demandcommercial markets. Fruehauf joins ViaLogy from Frequency Electronics Inc. (FEI), a leadingmanufacturer of precision frequency sources and frequency/time systems forsatellites, missiles, aircraft and a host of ground platforms, where he was VicePresident and Chief Technology Officer (CTO). Hugo has also held President/CEOand CTO positions at subsidiaries of FEI, the Defense Group of AlliantTechsystems, Datum Inc., and Ball-Efratom (a Ball Aerospace company); companiesserving both commercial and military/governmental system markets. Prior tothese roles, while at Rockwell International, he was the Chief Engineer for thedesign and development of the satellite for the now famous GPS GlobalPositioning System. He also played a leading role in the Apollo moon landingprogram, as Chief Test Conductor and Complex Operations Manager for the secondstage of the Saturn V launch vehicle. Mr. Fruehauf is considered a leading expert in GPS navigation, positioning andprecision timing for commercial and military applications, as well as precisionfrequency sources and network cryptographic security technologies. He is also anAdjunct Professor at Pepperdine University. Commenting on his appointment Hugo Fruehauf said: "I'm looking forward to leading an incredibly competent team at the Pasadenafacility and hopefully contribute to innovation, a systems engineering focus,and the operational glue that will bring ViaLogy to its full potential." Welcoming Hugo to ViaLogy, Dr. Robert W. Dean, President/CEO, said: "We are delighted that Hugo is joining the team at ViaLogy. He brings a wealthof experience in product design and development that will be vital as weroll-out our products to the market. We are all looking forward to an excitingyear ahead." Mr. Fruehauf is a Registered Professional Engineer in Control Systems (State ofCalifornia); an Executive MBA graduate (Pepperdine University); an ElectronicEngineering Technology graduate (DeVry University); the compiler of a "PrecisionTime and Frequency Handbook" and a religious book "God Without Dogma"; author ofmany technical papers on atomic oscillators, telecommunications, networkcryptography, and GPS technologies; holds numerous patents; and received awardsfor his role in the Apollo program, GPS, and an IEEE technical paper. ViaLogyRobert W Dean, President/CEO - US +1 626-296-6337 (mobile: +1 703-589-3807)Terry Bond, Chairman - UK & Europe +44 (0) 1235-834734 Nominated Advisor (Seymour Pierce)Mark Percy +44 (0) 20-7107-8000 PR Consultants - Redleaf CommunicationsEmma Kane / Samantha Robbins +44 (0) 20-7822-0200 About ViaLogy: Network Centric Signal Processing. ViaLogy is a leading innovator of network-centric, real-time signal processingplatforms for sensor applications and sensor fusion. ViaLogy is currentlydeploying and designing computational systems, powered by its patentedtechnologies, for applications in life sciences, public safety and security,surveillance, defense and geoseismology. Vialogy focuses on market drivenproblems where automation, timeliness, quality and reliability of informationprocessing are essential. ViaLogy's core competency incorporates rapidly andaccurately detecting weak signals buried in high noise background and clutter.This technology can be employed to solve problems involving sensor integrationand information overload challenges involving video, telephony and controlsensors, as well as for enhancement of numerous signal processing applications.For more information, visit our website at www.vialogy.com. Except for statements of historical fact, the information presented hereinconstitutes forward-looking statements within the meaning of the PrivateSecurities Litigation Reform Act of 1995. Such forward-looking statementsinvolve known and unknown risks, uncertainties and other factors which may causethe actual results, performance or achievements of the company to be materiallydifferent from any future results, performance or achievements expressed orimplied. This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
1st Apr 201912:12 pmRNSHolding(s) in Company
25th Mar 20197:00 amRNSYourgene raises IONA® test awareness in Egypt
26th Feb 20193:21 pmRNSHolding(s) in Company
22nd Feb 201910:00 amEQSHardman & Co Research: Yourgene Health (YGEN): EBITDA-positive in fiscal 2020
22nd Feb 20198:05 amRNSHolding(s) in Company
19th Feb 20192:21 pmRNSHolding(s) in Company
19th Feb 20197:15 amEQSHardman & Co Research: Yourgene Health (YGEN): Transformed and de-risked
18th Feb 201910:59 amRNSIssue of Equity
18th Feb 20197:00 amRNSMajor Capital & Commercial Restructuring
8th Jan 20197:00 amRNSYourgene launches Sage 32 plex
3rd Dec 20187:00 amRNSHalf-year Results
7th Nov 20187:00 amRNSChange of Name to Yourgene Health plc
5th Nov 201811:24 amRNSShare Transfer
2nd Nov 20187:00 amRNSDirectorate Change
25th Oct 20183:30 pmRNSResult of AGM
25th Oct 20187:00 amRNSHolding(s) in Company
25th Oct 20187:00 amRNSAGM Statement
22nd Oct 20187:00 amRNSFurther re: Fundraise
12th Oct 20181:15 pmRNSAvailability of Research Commentary
12th Oct 20187:00 amRNSTrading Update and Notice of Results
5th Oct 20187:00 amRNSDirector's dealing and share option issue
4th Oct 20187:00 amRNS$1 million collaboration agreement
3rd Oct 20187:00 amRNSDirectorate change
2nd Oct 20187:00 amRNSNotice of AGM
1st Oct 201812:20 pmRNSResult of Fundraise
28th Sep 20185:41 pmRNSProposed fundraise to raise approximately £2.5m
28th Sep 20185:40 pmRNSFull year results and half-year trading update
25th Sep 201811:31 amRNSHolding(s) in Company
21st Sep 20184:10 pmRNSHolding(s) in Company
21st Sep 20187:00 amRNSHolding(s) in Company
20th Sep 20189:30 amRNSSenior Appointment & Anticipated Director Change
19th Sep 201811:05 amRNSSecond Price Monitoring Extn
19th Sep 201811:00 amRNSPrice Monitoring Extension
19th Sep 20187:00 amRNSLegal Settlement & Licence Agreement with Illumina
11th Sep 20187:00 amRNSHolding(s) in Company
7th Aug 201810:57 amRNSHolding(s) in Company
12th Jul 20187:00 amRNSShare option awards
4th Jul 20187:00 amRNSBoard Changes
26th Jun 20181:31 pmRNSCollaboration with Abnova
13th Jun 20187:00 amRNSOutstanding NIPS Solution Provider Award Win
11th Jun 20187:00 amRNSDNA sequencing technology development agreement
7th Jun 20183:44 pmRNSHolding(s) in Company
5th Jun 20187:00 amRNSPremaitha signs partnership agreement in India
4th Jun 201811:05 amRNSHolding(s) in Company
24th May 20187:00 amRNSHolding(s) in Company
18th May 20184:38 pmRNSHolding(s) in Company
18th May 201812:06 pmRNSHolding(s) in Company
18th May 201812:05 pmRNSHolding(s) in Company
18th May 20189:40 amRNSHoldings in Company
15th May 20187:00 amRNSPremaitha expands footprint with new laboratories

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.